Matthew Rose‐Zerilli

Also affiliated with University of Southampton

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment”.

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Blood Advances(2021)10.1182/bloodadvances.2021004770

N/A

0.660DataRank · unranked

19 citations

Laura K. Hilton, Margaret Ashton‐Key, Chantal E. Hargreaves, Chern Siang Lee, Russell B. Foxall +23 more

Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100541

N/A

0DataRank · unranked

24 citations

Annette Hayden, Antigoni Manousopoulou, Andrew Cowie, Robert Walker, Jack Harrington +20 more